» Articles » PMID: 7023927

Role of Cadmium in Carcinogenesis with Special Reference to Cancer of the Prostate

Overview
Date 1981 Aug 1
PMID 7023927
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

It has been shown in animal experiments that injections of large amounts of cadmium cause sarcoma at injection sites or testicular damage and eventually testicular tumors. Long-term exposure with small doses of cadmium has not caused testicular or prostatic tumors in experimental animals. Epidemiological studies on cadmium-exposed workers have shown excess deaths due to prostatic cancer in at least three independent investigations. All reported cases probably had considerable exposure decades ago, but there are not enough data to permit any dose-response calculations. The general epidemiology of prostatic cancer was not taken into account in any of the studies. A review of recent literature on epidemiology of prostatic cancer has revealed some basic facts. Small latent prostatic cancer has been shown to be as common in areas with low mortality from prostatic cancer as in areas with high mortality. In the U.S. the black population has a much higher death rate from prostatic cancer than the white population. Marital status has also been implied as a factor in the development of prostatic cancer. Black populations in Africa have much lower death rates than blacks in the U.S., which may depend on large differences in dietary habits. Thus racial, sexual and nutritional factors might be important for the development of prostatic cancer, since they may influence hormonal status. Cadmium concentrations in testes and prostate increase during heavy exposure, and it has been shown that testosterone synthesis will decrease in cadmium-exposed animals. Excessive exposure may interfere with the zinc/hormone relationship in the prostate, which could be a possible explanation for the development of prostatic cancer in heavily exposed individuals. Direct action of cadmium on the cells is not likely, nor is it probable that low level exposure to cadmium can be a causative factor for prostatic cancer.

Citing Articles

Ambient exposures to selected volatile organic compounds and the risk of prostate cancer in Montreal.

Goldberg M, Zapata-Marin S, Labreche F, Ho V, Lavigne E, Valois M Environ Epidemiol. 2022; 6(6):e231.

PMID: 36530935 PMC: 9746733. DOI: 10.1097/EE9.0000000000000231.


Nrf2 in liver toxicology.

Taguchi K, Kensler T Arch Pharm Res. 2019; 43(3):337-349.

PMID: 31782059 PMC: 7182086. DOI: 10.1007/s12272-019-01192-3.


Occupational Risk Factors for Prostate Cancer: A Meta-analysis.

Krstev S, Knutsson A J Cancer Prev. 2019; 24(2):91-111.

PMID: 31360689 PMC: 6619854. DOI: 10.15430/JCP.2019.24.2.91.


In vitro assessment of the toxicity of metal compounds : II. Mutagenesis.

Heck J, Costa M Biol Trace Elem Res. 2013; 4(4):319-30.

PMID: 24272138 DOI: 10.1007/BF02786545.


In vitro assessment of the toxicity of metal compounds : I. Mammalian Cell transformation.

Heck J, Costa M Biol Trace Elem Res. 2013; 4(2-3):71-82.

PMID: 24271980 DOI: 10.1007/BF02783248.


References
1.
AKAZAKI K, Stemmerman G . Comparative study of latent carcinoma of the prostate among Japanese in Japan and Hawaii. J Natl Cancer Inst. 1973; 50(5):1137-44. DOI: 10.1093/jnci/50.5.1137. View

2.
Schroeder H, Balassa J, Vinton Jr W . CHROMIUM, CADMIUM AND LEAD IN RATS: EFFECTS ON LIFE SPAN, TUMORS AND TISSUE LEVELS. J Nutr. 1965; 86:51-66. DOI: 10.1093/jn/86.1.51. View

3.
Lemen R, Lee J, Wagoner J, Blejer H . Cancer mortality among cadmium production workers. Ann N Y Acad Sci. 1976; 271:273-9. DOI: 10.1111/j.1749-6632.1976.tb23122.x. View

4.
KERR W, KERESTECI A, MAYOH H . The distribution of zinc within the human prostate. Cancer. 1960; 13:550-4. DOI: 10.1002/1097-0142(196005/06)13:3<550::aid-cncr2820130320>3.0.co;2-x. View

5.
Greenwald P, Kirmss V, Burnett W . Prostate cancer epidemiology: widowerhood and cancer in spouses. J Natl Cancer Inst. 1979; 62(5):1131-6. View